Terms: = Head and neck cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
123 results:
1. cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to fgfr2.
Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
[TBL] [Abstract] [Full Text] [Related]
2. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
3. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Piha-Paul SA; Xu B; Dumbrava EE; Fu S; Karp DD; Meric-Bernstam F; Hong DS; Rodon JA; Tsimberidou AM; Raghav K; Ajani JA; Conley AP; Mott F; Fan Y; Fan J; Peng P; Wang H; Ni S; Sun C; Qiang X; Levin WJ; Ngo B; Ru QC; Wu F; Javle MM
Oncologist; 2024 Apr; 29(4):e514-e525. PubMed ID: 38297981
[TBL] [Abstract] [Full Text] [Related]
4. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
5. FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
[TBL] [Abstract] [Full Text] [Related]
6. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
7. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin.
Liang WW; Lu RJ; Jayasinghe RG; Foltz SM; Porta-Pardo E; Geffen Y; Wendl MC; Lazcano R; Kolodziejczak I; Song Y; Govindan A; Demicco EG; Li X; Li Y; Sethuraman S; Payne SH; Fenyö D; Rodriguez H; Wiznerowicz M; Shen H; Mani DR; Rodland KD; Lazar AJ; Robles AI; Ding L;
Cancer Cell; 2023 Sep; 41(9):1567-1585.e7. PubMed ID: 37582362
[TBL] [Abstract] [Full Text] [Related]
8. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
9. Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.
Javle M; King G; Spencer K; Borad MJ
Oncologist; 2023 Nov; 28(11):928-943. PubMed ID: 37390492
[TBL] [Abstract] [Full Text] [Related]
10. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal cancers.
Lee MS; Kaseb AO; Pant S
Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
[TBL] [Abstract] [Full Text] [Related]
11. Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.
Povýšil C; Hojný J; Kaňa M
Folia Biol (Praha); 2022; 68(3):112-124. PubMed ID: 36689318
[TBL] [Abstract] [Full Text] [Related]
12. fgfr2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
Albin J; Fahrig L; Siemanowski J; Rehkaemper J; Gebauer F; Zander T; Buettner R; Bruns CJ; Schroeder W; Alakus H; Hieggelke L; Quaas A
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5289-5300. PubMed ID: 36416959
[TBL] [Abstract] [Full Text] [Related]
13. [Oesogastric cancer - new therapeutic targets].
Palmieri LJ; Soubeyran I; Pernot S
Bull Cancer; 2023 May; 110(5):560-569. PubMed ID: 36371284
[TBL] [Abstract] [Full Text] [Related]
14. N-nitrosamines-mediated downregulation of LncRNA-UCA1 induces carcinogenesis of esophageal squamous by regulating the alternative splicing of fgfr2.
Wang X; Sun M; Gao Z; Yin L; Pu Y; Zhu Y; Wang X; Liu R
Sci Total Environ; 2023 Jan; 855():158918. PubMed ID: 36169023
[TBL] [Abstract] [Full Text] [Related]
15. Identification and characterization of fgfr2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract] [Full Text] [Related]
16. Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study.
de Paula Souza DPS; Dos Reis Pereira Queiroz L; de Souza MG; de Jesus SF; Gomes ESB; Vitorino RT; Santos SHS; Farias LC; de Paula AMB; D'Angelo MFSV; de Carvalho Fraga CA; Guimarães ALS
Oral Dis; 2023 Oct; 29(7):2658-2666. PubMed ID: 35796645
[TBL] [Abstract] [Full Text] [Related]
17. Precision medicine: Sustained response to erdafitinib in fgfr2-mutant, multiply recurrent ameloblastoma.
Lawson-Michod KA; Le CH; Tranesh G; Thomas PC; Bauman JE
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1656. PubMed ID: 35761436
[TBL] [Abstract] [Full Text] [Related]
18. Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Kleo K; Jovanovic VM; Arndold A; Lehmann A; Lammert H; Berg E; Harloff H; Treese C; Hummel M; Daum S
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1049-1061. PubMed ID: 35246724
[TBL] [Abstract] [Full Text] [Related]
19. Ameloblastoma with adenoid features: Case report with cyto-histopathologic correlation and molecular findings.
Jofre SA; Roth M; Lahouti AH; Gersten A; Azad AK; Kelsch RD; Asiry S; Goldstein Y; Naeem R; Rao R
Diagn Cytopathol; 2022 Jun; 50(6):E140-E145. PubMed ID: 35077030
[TBL] [Abstract] [Full Text] [Related]
20. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
[TBL] [Abstract] [Full Text] [Related]
[Next]
